Janssen Research and Development, a Johnson & Johnson subsidiary, will launch the first clinical trial to use its iSTEP technology toolset, which employs smart blisterpacks and a patient-facing ...
Janssen Defends Data Reanalysis in Risperdal Trial A Janssen Pharmaceuticals official and the statistician who recently conducted a hotly contested reanalysis of data purportedly linking Risperdal to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results